Hi everyone,
I've been scheduled to have Impact Testing (Integrated Mutation Profiling of Actionable Cancer Targets) where they sample blood and nail clippings. Is anyone familiar with this?
Hi everyone,
I've been scheduled to have Impact Testing (Integrated Mutation Profiling of Actionable Cancer Targets) where they sample blood and nail clippings. Is anyone familiar with this?
I had not heard of this under this name before. Using next generation sequencing to more specifically tailor treatment for cancer is a very promising step forward. mskcc.org/msk-impact
Please let us know what you learn from the IMPACT study. We can all benefit from what you learn. Thanks for sharing this.
Hi Hunter, thank you for your response. I will share what I learn from this testing, which I was told takes about 5 weeks.
Hi Violetta! I was wondering how things went. That study sounds interesting.
Hi GrammyG. I was all set to have this testing done but my insurance would not cover it and the cost would be in the thousands. I had some genetic testing done with my initial bone marrow biopsy and I have the Jak2 V617F mutation reflex to JAK2 Exon 12 and a TET2 mutation. I am currently taking 500mg of Hydroxyurea and 2 baby aspirins daily. My current blood tests are in the normal range. My MPN specialist has suggested I switch to Peg-interferon or Ropeg-interferon in about 3 months. My diagnosis was PV but now I am MPN-U . He said I could have Next Generation Sequencing before then.
It seems this test may be a newer tech, which could explain why your ins would not pay. It may be uniquely or mostly provided by Sloan Kettering Institute
With 400 genes, this is a very broad test. My nexgen test was for only 54 of them. I would expect it's cheaper per gene.
From the link Hunter noted:
<<A companion test for people with blood cancer MSK-IMPACT Heme, has also been validated and is in use. That test evaluates 400 genes, many of them the same genes that are included for solid tumors>>
It's a good idea that you will get Nex gen before starting INF therapy so you have a base line to compare any changes in mutation burdens.
I recently ruled out any autoimmune diseases with a rheumatologist which was important if I were to start on either interferon therapy.